NCT00809198已完成4 期
The Effect of Kynex Versus Refresh Plus in Subjects With Mild to Moderate Dry Eye - A Parallel Group, Randomized, Masked Study
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 67
- 主要终点
- Cornea Staining Score
研究概览
简要总结
The effect of Kynex versus Refresh Plus in subjects with mild to moderate dry eye.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •20 years of age or older, of any race and either sex.
- •Able to understand and sign an informed consent that has been approved by an Institutional Review Board.
- •Criteria for the diagnosis must include the following two characteristics at Visit 1 (Day 1):
- •Subjects' assessment of dry eye status (answer of at least "Some of the time" to the question, "How often have your eyes felt dry enough to want to use eye drops?"
- •Sodium fluorescein (NaFl) corneal staining score sum of ≥3 in either eye (NEI scoring system).
- •Able and willing to follow study instructions.
排除标准
- •Subjects who meet any of the following criteria will be excluded from this study:
- •History or evidence of ocular or intraocular surgery in either eye within the past three months.
- •History of intolerance or hypersensitivity to any component of the study medications.
- •History or evidence of epithelial herpes simplex keratitis (dendrictic keratitis); vaccine, active or recent varicella viral disease of the cornea and/or conjunctiva; ocular rosacea; chronic bacterial disease of the cornea and/or conjunctiva and/or eyelids; mycobacterial infection of the eye; and/or fungal disease of the eye.
- •Use of topical ocular medications during the study period.
- •Subjects using systemic medications that may contribute to dry eye (e.g. cold and allergy medications, tricyclic antidepressants, hormone replacement therapies) may not be enrolled in the study unless they have been on a stable dosing regimen for a minimum of 30 days prior to Visit
- •In addition, the dosing regimen must remain stable throughout the study.
- •Presence of ocular conditions such as active acute blepharitis, conjunctival infections, iritis, or any other ocular condition that may preclude the safe administration of the test article.
- •Subjects unwilling to discontinue contact lens wear during the study period. Contact lens wear must have been discontinued at least one week prior to Visit
- •Current punctal occlusion of any type (e.g. collagen plugs, silicone plugs).
- •Enrollment of the investigator or his or her staff, family members of the investigator, family members of the investigator's staff, or individuals living in the households of these individuals.
- •Participation in any investigational drug or device study within 30 days of entering this study.
结局指标
主要结局
Cornea Staining Score
时间窗: 8 weeks
次要结局
- Dry Eye and symptoms(8 weeks)
研究者
相似试验
招募中
2 期
Comparison of clinical outcome in dry eye treatment between corneal epithelial thickness assessment with spectral domain optical coherence tomography and clinical assessmentCorneal epithelial thickness measured by spectral domain optical coherence tomography can use for grading dry eye severity and have effect on treatment efficacyCorneal epithelial thickness, spectral domain optical coherence tomography, dry eye diseaseTCTR20210706006/A92
尚未招募
不适用
the effect of Prokera slim in dry eye syndromeDry eye syndromeJPRN-UMIN000022620Minami Aoyama Eye Clinic10
已完成
不适用
Comparison of dry eye syndrome and corneal sensation after femtosecond- and microkeratome-assisted LASIKearsightedness (myopia)Eye DiseasesMyopiaISRCTN43661922Chang Gung Memorial Hospital (Taiwan)200
已完成
4 期
Effects of Dry Eye Treatments on the Ocular SurfaceKeratoconjunctivitis SiccaDry Eye SyndromeNCT01797822Baylor College of Medicine20
已完成
不适用
Effect of multi supplement on Dry Eye Syndromedry eyeJPRN-UMIN000014447dry eye KT40